title: sciPlex_4
organism: Homo sapiens
attributes.tag: source_name
attributes.value: A172, T98G and U87MG cells
attributes.tag: cell line
attributes.value: A172, T98G and U87MG cells
attributes.tag: cell type
attributes.value: Human glioblastoma brain cancer cells
attributes.tag: treatment
attributes.value: Cells were treated with increasing doses of the small molecules Alectinib, AZ628, AZD7762, BI-D1870, BM3-345541, DDR1-IN-1, Doxorubicin, GSK690693, Infigratinib, KU-5933, MK-2206, Nintedanib, Nutlin-3A, Palbociclib, PHA-767491, RIPA-56, Roscovitine, Salubrinal, Temozolomide, Temsirolimus, VE-821, Volasertib or dmso vehicle control in the absence or presence of trametinib co-exposure.